Proteome Sciences (LON:PRM) Stock Price Down 15.2% – Here’s Why

Proteome Sciences plc (LON:PRM)’s share price traded down 15.2% during mid-day trading on Tuesday . The stock traded as low as GBX 1.40 and last traded at GBX 1.40. Approximately 455,574 shares were traded during trading, an increase of 10% from the average daily volume of 414,862 shares. The stock had previously closed at GBX 1.65.

Proteome Sciences Trading Down 15.2%

The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The firm has a market cap of £4.91 million, a price-to-earnings ratio of -1.35 and a beta of 0.15. The business’s 50-day moving average price is GBX 1.59 and its two-hundred day moving average price is GBX 1.88.

Proteome Sciences (LON:PRM) last released its earnings results on Wednesday, April 15th. The company reported GBX (1.04) EPS for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.The firm had revenue of GBX 376 million during the quarter.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.